Medical and Pharmaceutical Neurogene patient dies in drug trial, stock surges after FDA says ‘use lower dose’ This unfortunate incident occurred during a study on the company's Rett syndrome therapeutic NGN-401 Rowan DunneNovember 22, 2024
Medical and Pharmaceutical Capricor Therapeutics gains traction with impending treatment data reveal in Czechia The biotech company will be revealing 3-year safety data on its primary drug for Duchenne muscular dystrophy next week Rowan DunneOctober 4, 2024
AI and Autonomy Ontario scientists create AI algorithm to identify rare disorders in kids ThinkRare, developed at the Children's Hospital of Eastern Ontario, took three years of research to make Rowan DunneMay 23, 2024